- Medical School - UT Southwestern Medical School (2007-2011)
- Fellowship - Beth Isreal Deaconess Medical Center (2015-2018), Gastroenterology
- Residency - Columbia University Medical Center/New York Presbyterian Hospital (2011-2014), Internal Medicine
David Fudman, M.D.
- Internal Medicine - Digestive and Liver Diseases
- Liver Disease
David I. Fudman, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He is a gastroenterologist who specializes in the treatment of inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis.
Dr. Fudman earned his medical degree at UT Southwestern Medical School. He completed a residency in internal medicine at New York-Presbyterian/Columbia University Medical Center and then obtained advanced training in treating inflammatory bowel disease through a fellowship in gastroenterology and hepatology at Beth Israel-Deaconess Medical Center/Harvard Medical School.
Board certified in internal medicine, he joined the UT Southwestern faculty in 2018.
Dr. Fudman, whose research interests include quality improvement, has delivered scores of presentations and published numerous academic articles.
Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease in Treatment of Inflammatory Bowel Disease with Biologics
Fudman DI, Flier SN (2017), Springer
- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease in Treatment of Inflammatory Bowel Disease with Biologics
Inpatient Management of Acute Severe Ulcerative Colitis.
Fudman DI, Sattler L, Feuerstein JD, Journal of hospital medicine 2019 May 14 E1-E8
Positive correlation between endoscopist radiofrequency ablation volume and response rates in Barrett's esophagus.
Fudman DI, Lightdale CJ, Poneros JM, Ginsberg GG, Falk GW, Demarshall M, Gupta M, Iyer PG, Lutzke L, Wang KK, Abrams JA Gastrointestinal endoscopy 2014 Jul 80 1 71-7
Effect of Consent and Educational Adjuncts to Consent on Patient Perceptions About Colonoscopy.
Fudman DI, Papamichael K, Roemi L, Rao V, Falchuk KR, Leffler DA, Feuerstein JD Journal of clinical gastroenterology 2018 Jul
Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
Gu P, Chhabra A, Chittajallu P, Chang C, Mendez D, Gilman A, Fudman DI, Xi Y, Feagins LA, Inflammatory bowel diseases 2021 Jul
Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review.
Fudman DI, Perez-Reyes AE, Niccum BA, Melmed GY, Khalili H, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Sep
Prevalence of Forceps Polypectomy of Non-Diminutive Polyps is Substantial but Modifiable.
Fudman DI, Singal AG, Cooper MG, Lee M, Murphy CC, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Nov
Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
Gupta M, Iyer PG, Lutzke L, Gorospe EC, Abrams JA, Falk GW, Ginsberg GG, Rustgi AK, Lightdale CJ, Wang TC, Fudman DI, Poneros JM, Wang KK Gastroenterology 2013 Jul 145 1 79-86.e1
Predictors Of Treatment Failure After Radiofrequency Ablation For Intramucosal Adenocarcinoma in Barrett Esophagus: A Multi-institutional Retrospective Cohort Study.
Agoston AT, Strauss AC, Dulai PS, Hagen CE, Muzikansky A, Fudman DI, Abrams JA, Forcione DG, Jajoo K, Saltzman JR, Odze RD, Lauwers GY, Gordon SR, Lightdale CJ, Rothstein RI, Srivastava A The American journal of surgical pathology 2016 Apr 40 4 554-62
Complication rates of trainee- versus attending-performed upper gastrointestinal endoscopy.
Fudman DI, Falchuk KR, Feuerstein JD, Annals of gastroenterology 2019 May-Jun 32 3 273-277
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease.
Alayo QA, Fenster M, Altayar O, Glassner KL, Llano E, Clark-Snustad K, Patel A, Kwapisz L, Yarur AJ, Cohen BL, Ciorba MA, Thomas D, Lee SD, Loftus EV, Fudman DI, Abraham BP, Colombel JF, Deepak P, Crohn's & colitis 360 2022 Jan 4 1 otac002
High Rate of Incomplete Consent for Colonoscopy: Identifying an Area for Improvement in Gastrointestinal Endoscopy.
Fudman DI, Roemi L, Leffler DA, Feuerstein JD, American journal of medical quality : the official journal of the American College of Medical Quality 2019 Aug 1062860619868296
Fragmentation, Care Models, and Improving Outcomes in Inflammatory Bowel Disease.
Fudman DI, Hou JK, JAMA network open 2020 09 3 9 e2016122
Antibiotic prophylaxis and infectious complications in patients on peritoneal dialysis undergoing lower gastrointestinal endoscopy.
Clarke WT, Satyam VR, Fudman DI, Zullow S, Goyal KG, Byanova KL, Huang C, Feuerstein JD, Gastroenterology report 2020 Oct 8 5 407-409
- Inpatient Management of Acute Severe Ulcerative Colitis.
- Liver Disease